Skip to main content
Bedaquiline, Pretomanid, Moxifloxacin, Pyrazinamide
Compounds in Regimen
Currently under investigation in the SimpliciTB Trial. Click associated trial link for more details.
Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients. ClinicalTrials.gov Identifier: NCT03338621
A Phase 2 Open Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis. (
EFFICACY OF BEDAQUILINE, PRETOMANID, MOXIFLOXACIN & PZA (BPAMZ) AGAINST DS- & MDR-TB
©2016 Working Group on New TB Drugs. All Rights Reserved.
Terms of Reference
Site by Darby Communications